These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33476933)

  • 1. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.
    Zhang G; Li S; Wang F; Jones AC; Goldberg AFG; Lin B; Virgil S; Stoltz BM; Deshaies RJ; Chou TF
    Eur J Med Chem; 2021 Mar; 213():113148. PubMed ID: 33476933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric p97 Inhibitors Can Overcome Resistance to ATP-Competitive p97 Inhibitors for Potential Anticancer Therapy.
    Wang F; Li S; Gan T; Stott GM; Flint A; Chou TF
    ChemMedChem; 2020 Apr; 15(8):685-694. PubMed ID: 32162487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
    Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
    J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex.
    Fang CJ; Gui L; Zhang X; Moen DR; Li K; Frankowski KJ; Lin HJ; Schoenen FJ; Chou TF
    ChemMedChem; 2015 Jan; 10(1):52-6. PubMed ID: 25377500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death.
    Magnaghi P; D'Alessio R; Valsasina B; Avanzi N; Rizzi S; Asa D; Gasparri F; Cozzi L; Cucchi U; Orrenius C; Polucci P; Ballinari D; Perrera C; Leone A; Cervi G; Casale E; Xiao Y; Wong C; Anderson DJ; Galvani A; Donati D; O'Brien T; Jackson PK; Isacchi A
    Nat Chem Biol; 2013 Sep; 9(9):548-56. PubMed ID: 23892893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p97 Composition Changes Caused by Allosteric Inhibition Are Suppressed by an On-Target Mechanism that Increases the Enzyme's ATPase Activity.
    Her NG; Toth JI; Ma CT; Wei Y; Motamedchaboki K; Sergienko E; Petroski MD
    Cell Chem Biol; 2016 Apr; 23(4):517-28. PubMed ID: 27105284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.
    Zhang Y; Xie X; Wang X; Wen T; Zhao C; Liu H; Zhao B; Zhu Y
    Bioorg Med Chem; 2021 May; 38():116114. PubMed ID: 33831696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.
    Lan B; Chai S; Wang P; Wang K
    Curr Mol Med; 2017; 17(9):608-618. PubMed ID: 29521227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways.
    Chou TF; Brown SJ; Minond D; Nordin BE; Li K; Jones AC; Chase P; Porubsky PR; Stoltz BM; Schoenen FJ; Patricelli MP; Hodder P; Rosen H; Deshaies RJ
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4834-9. PubMed ID: 21383145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis of p97 Inhibition by the Site-Selective Anticancer Compound CB-5083.
    Tang WK; Odzorig T; Jin W; Xia D
    Mol Pharmacol; 2019 Mar; 95(3):286-293. PubMed ID: 30591537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase.
    Chou TF; Li K; Frankowski KJ; Schoenen FJ; Deshaies RJ
    ChemMedChem; 2013 Feb; 8(2):297-312. PubMed ID: 23316025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.
    Wang X; Bai E; Zhou H; Sha S; Miao H; Qin Y; Liu Z; Wang J; Zhang H; Lei M; Liu J; Hai O; Zhu Y
    Bioorg Med Chem; 2019 Feb; 27(3):533-544. PubMed ID: 30606672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase.
    Wang K; Chen L; Dai X; Ye Z; Zhou C; Zhang CJ; Feng Z
    Eur J Med Chem; 2023 Feb; 248():115094. PubMed ID: 36634454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Molecule Modulators of the ATPase VCP/p97 Affect Specific p97 Cellular Functions.
    Figuerola-Conchas A; Saarbach J; Daguer JP; Cieren A; Barluenga S; Winssinger N; Gotta M
    ACS Chem Biol; 2020 Jan; 15(1):243-253. PubMed ID: 31790201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of p97 by chlorinated analogues of dehydrocurvularin.
    Tillotson J; Bashyal BP; Kang M; Shi T; De La Cruz F; Gunatilaka AA; Chapman E
    Org Biomol Chem; 2016 Jul; 14(25):5918-21. PubMed ID: 27223265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.
    Cervi G; Magnaghi P; Asa D; Avanzi N; Badari A; Borghi D; Caruso M; Cirla A; Cozzi L; Felder E; Galvani A; Gasparri F; Lomolino A; Magnuson S; Malgesini B; Motto I; Pasi M; Rizzi S; Salom B; Sorrentino G; Troiani S; Valsasina B; O'Brien T; Isacchi A; Donati D; D'Alessio R
    J Med Chem; 2014 Dec; 57(24):10443-54. PubMed ID: 25474526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of p97 AAA ATPase inhibitors.
    Chou TF; Deshaies RJ
    Autophagy; 2011 Sep; 7(9):1091-2. PubMed ID: 21606684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis.
    Anderson DJ; Le Moigne R; Djakovic S; Kumar B; Rice J; Wong S; Wang J; Yao B; Valle E; Kiss von Soly S; Madriaga A; Soriano F; Menon MK; Wu ZY; Kampmann M; Chen Y; Weissman JS; Aftab BT; Yakes FM; Shawver L; Zhou HJ; Wustrow D; Rolfe M
    Cancer Cell; 2015 Nov; 28(5):653-665. PubMed ID: 26555175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.